Slate Path Capital LP Teva Pharmaceutical Industries LTD Transaction History

Slate Path Capital LP

$5.05 Billion
Q1 2025

A detailed history of Slate Path Capital LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Slate Path Capital LP holds 9,655,998 shares of TEVA stock, worth $160 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares

9,655,998

Previous 8,491,033 13.72%

Holding current value

$160 Million

Previous $187 Million 20.7%

% of portfolio

2.94%

Previous 3.6%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$14.67 - $22.01 $17.1 Million - $25.6 Million	1,164,965 Added 13.72%	9,655,998 $148 Million
Q4 2024 Feb 14, 2025	SELL	$16.43 - $22.77 $85.1 Million - $118 Million	-5,177,200 Reduced 37.88%	8,491,033 $187 Million
Q3 2024 Nov 14, 2024	SELL	$15.81 - $18.96 $103 Million - $124 Million	-6,522,951 Reduced 32.31%	13,668,233 $246 Million
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $85.7 Million - $117 Million	-6,705,000 Reduced 24.93%	20,191,184 $328 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $7.1 Million - $9.6 Million	665,000 Added 2.54%	26,896,184 $380 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $19.4 Million - $25.4 Million	2,387,184 Added 10.01%	26,231,184 $274 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $85.3 Million - $122 Million	11,407,000 Added 91.72%	23,844,000 $243 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $89.5 Million - $118 Million	12,437,000 New	12,437,000 $93.7 Million

Others Institutions Holding TEVA

# of Institutions

659

Shares Held

627M

Call Options Held

27.9M

Put Options Held

21.8M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Path Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Slate Path Capital LP with notifications on news.

Account

Slate Path Capital LP Teva Pharmaceutical Industries LTD Transaction History